WhiteOak Capital Pharma and Heathcare Fund: AUM ₹133 Cr, expense ratio 1.28%, 1Y return +18.24%. Track returns, risk and NAV history.
| Fund House (AMC) | WhiteOak Capital Mutual Fund |
|---|---|
| Category | Equity Scheme - Sectoral/ Thematic |
| Scheme Code | 152349 |
| ISIN | INF03VN01886 |
| AUM | ₹133 Cr |
| Expense Ratio | 1.28% |
| Launch Date | 16-01-2024 (2.9 yrs) |
| 1-Year Return | +18.24% |
| Alpha (vs Nifty 50) | +23.15% |
| Standard Deviation | 13.80% |
| Sortino Ratio | 1.30 |
| Exit Load | Entry Load: Nil Exit Load: Nil |
You can check the live AMFI NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth (Scheme Code: 152349) on this page or in our Live Data scanner.
The expense ratio of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 1.28% per annum, deducted daily from the scheme's Net Asset Value (NAV).
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth manages Assets Under Management (AUM) of approximately ₹133 Cr and was launched on 16-01-2024.
Trailing annualized returns for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 1-Year: +18.24%. Past performance is not indicative of future results.
The AMFI scheme code for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 152349 and its ISIN is INF03VN01886. It is managed by WhiteOak Capital Mutual Fund.